AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi ...

FRANKFURT: European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

EUROPEAN shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

European shares fell on Tuesday on the back of poor performances from the banking and defence sectors, as uncertainty ...

By Sukriti Gupta, Sanchayaita Roy and Shashwat Chauhan (Reuters) -European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed uncertainty over U.

Solana underwhelms in H1, but this week's key positive developments (ETFs and tokenized stocks) could set the tone for H2.

(Reuters) -AstraZeneca chief executive Pascal Soriot is considering moving the company's stock market listing to the United ...

There are great global stocks we can buy other than US shares. The post Worried about US shares? I'd look at buying these two ...

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Europe's military capabilities remain heavily reliant on the US, while both Russia and China have substantially advanced ...